| Sub-Segment | Typical Borrower (EU) |
|---|---|
| Direct Lending | PE-backed; €15M–500M EBITDA; profitable; 3–6x lev. |
| Asset-Backed / Trade Finance | Asset pools (mortgages, trade rec., leases); no single obligor |
| Distressed / Spec. Sits. | Stressed/restructuring cos; overleveraged; wide EBITDA range |
| Specialty Finance | Healthcare rec., royalties, equipment leasing; asset-backed |
| Mezzanine Debt | PE LBO/expansion; €10–75M EBITDA; 4–6x lev.; equity kicker |
| Growth Debt ★ | VC-backed; €1–50M Sales; EBITDA –ve to BE; Pre-Series A–D; tech/life sci. |
Research, market commentary, and notes from the GrowthPath team. No sponsored content, no syndicated material. Everything here is written in‑house.
A 20-page analysis of the structural gap in European growth credit: the evolution of the asset class, market sizing, the competitive landscape, and the European deal pipeline. Updated Q1 2026.
When founders weigh debt against equity, they compare the wrong number. The interest rate is not the cost that matters. Set the total cost of each option against the other, measured at the exit you are aiming for.
Read article →Most founders ask whether they should take debt. The right question is whether the business can actually carry it. Here is what has to be true before debt makes sense, and the five situations where borrowing is the wrong answer.
Read article →European growth debt posted its strongest quarter in years, but deal count fell for the fourth consecutive quarter. What the headline figure hides, and why the companies that hold their credit value when conditions tighten are rarely the fastest growers.
Read article →
What makes Early-Stage Growth Lending the next opportunity

Building Lean: Lessons from a Solo GP and a Solo Entrepreneur
For press inquiries: alexandre@gpi-europe.com